BioMarin Pharma (BMRN) Misses Q1 EPS by 8c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $66.64 --0%
Financial Fact:
Weighted average common shares outstanding, diluted: 167.71M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Weighted average common shares outstanding, diluted: 167.71M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of ($0.26), $0.08 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $373.4 million versus the consensus estimate of $348.57 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- XP Inc. (XP) Tops Q2 EPS by 8c
- Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
